AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Feb 24, 2021
30016_dirs_2021-02-24_30d71789-74da-4c6a-900a-f9af21d2d879.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-22
Reporting Person: JUNIUS DANIEL M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-22 | Common Stock | M | 898 | $79.54 | Acquired | 3773 | Direct |
| 2021-02-22 | Common Stock | M | 1000 | $85 | Acquired | 4773 | Direct |
| 2021-02-22 | Common Stock | S | 10 | $539.19 | Disposed | 4763 | Direct |
| 2021-02-22 | Common Stock | S | 1888 | $538.5673 | Disposed | 2875 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-22 | Incentive Stock Option (right-to-buy) | $79.54 | M | 898 | Disposed | 2025-02-13 | Common Stock (898) | Direct |
| 2021-02-22 | Non-Qualified Stock Option (right-to-buy) | $85 | M | 1000 | Disposed | 2026-05-03 | Common Stock (1000) | Direct |
Footnotes
F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 449 shares on May 6, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
F3: Not applicable.